Hims & Hers is facing battles on multiple fronts as it seeks to maintain its lucrative business in copycat weight loss drugs.

Scientists raced to make drugs that help people lose as much weight as possible. Now they’re pumping the brakes.

A decade-long commitment to medically supervised care, advanced wellness therapies, and personalized health solutions ...

Researchers report that intermittent fasting is no more effective for weight loss than other dietary routines. Experts say ...

Soaring in popularity, GLP-1 medications—from weekly injections to newly available pills—are rapidly reshaping how Americans ...

An experimental combo drug from Novo Nordisk leads to more weight loss than semaglutide alone, according to late-stage trial data.

A November 2025 Kaiser Family Foundation poll found that 1 in 8 U.S. adults have tried a GLP-1 medication for weight loss, ...

A new study shows that people are likely to continue taking GLP-1 drugs like Ozempic, which is commonly prescribed off-label for weight loss, despite side effects like nausea, diarrhea, and abdominal ...

A public health expert explains how GLP-1 drugs have changed the way healthcare providers understand and treat obesity.

The popular eating strategy is about as effective as doing nothing to lose weight, according to a review of several clinical trials ...

With insurance plans dropping coverage of the drugs, those of us benefiting from them face a costly decision — beyond just the monetary.

A new study found that a combination of hormone therapy and the GLP-1 medication tirzepatide (Zepbound) led to 35% more ...